Stability indicating RP-HPLC method for simultaneous determination of simvastatin and ezetimibe from tablet dosage form

Indian Journal of Pharmaceutical Sciences

Volumn 72, Issue 2, 2010, Pages 204-210

  Dixit, R P ^a   Barhate, C R ^a   Padhye, S G ^a   Viswanathan, C L ^a   Nagarsenker, M S ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

Ezetimibe; reverse phase high performance liquid chromatography; simvastatin; stress degradation; tablets

Indexed keywords

ACETONITRILE; EZETIMIBE; PHOSPHATE BUFFERED SALINE; SIMVASTATIN; SIMVOTIN EZ; UNCLASSIFIED DRUG;

ARTICLE; COLUMN CHROMATOGRAPHY; DRUG DEGRADATION; DRUG DOSAGE FORM; DRUG STABILITY; ELUTION; FLOW RATE; PH; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TABLET FORMULATION; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

EID: 77954857744     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.65028     Document Type: Article

References (11)

1. Patil P, Patil V, Paradkar A. Formulation of a self-emulsifying system for oral delivery of simvastatin: In vitro and in vivo evaluation. Acta Pharm 2007;57:111-122
2. Kosoglou T, Statkevich P, Johnson-Levonas AO, Paolini JF, Bergman AJ, Alton KB. Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. Clin Pharmacokinet 2005;44:467-494
3. Alvarez-Lueje A, Valenzuela C, Squella JA, Nunez-Vergara LJ. Stability study of simvastatin under hydrolytic conditions assessed by liquid chromatography. J AOAC Int 2005;88:1631-1636
4. Wang L, Asgharnejad M. Second-derivative UV spectrometric determination of simvastatin in its tablet dosage form J Pharm Biomed Anal 2000;21:1243-1248
5. Vuletic M, Cindric M, Koruznjak JD. Identification of unknown impurities in simvastatin substance and tablets by liquid chromatography/tandem mass spectrometry. J Pharm Biomed Anal 2005;37:715-721
6. Sistla R, Tata VS, Kashyap YV, Chandrasekar D, Diwan PV. Development and validation of a reversed-phase HPLC method for the determination of ezetimibe in pharmaceutical dosage forms. J Pharm Biomed Anal 2005;39:517-522
7. Singh S, Singh B, Bahuguna R, Wadhwa L, Saxena R. Stress degradation studies on ezetimibe and development of a validated stability-indicating HPLC assay. J Pharm Biomed Anal 2006;41: 1037-1040
8. Andelija M, Darko I, Mirjana M, Biljana J, Slavko M. Influence of structural and interfacial properties of microemulsion eluent on chromatographic separation of simvastatin and its impurities. J Chromatogr A 2006;1131:67-73.
9. Ozaltin N, Ucaktiirk E. Simultaneous determination of ezetimibe and simvastatin in pharmaceutical formulations by dual-mode gradient LC. Chromatographia 2007;66:S87-S91.
10. Dixit RP, Barhate CR, Nagarsenker MS. Stability-Indicating HPTLC method for simultaneous determination of ezetimibe and simvastatin. Chromatographia 2008;67:101-107
11. USP 29/NF 24, The United States Pharmacopoeia, 29th Rev. and the National Formulary, 24th ed. Rockville, MD: United States Pharmacopoeial Convention Inc., 2006. p. 1964-1966